Consequently, the inhibition of AKT to activate GSK-3β in melanoma cells may result in the phosphorylation of Gle1A, which subsequently disassembled SGs, explaining the potential mechanism for the reduction of cell viability to ~50% observed at 72 h [603]. The gene discussed is GSK3B; the disease is melanoma.